US Stock MarketDetailed Quotes

SER Serina Therapeutics

Watchlist

10.444
+1.944+22.87%

Trading May 20 15:50 ET

87.87MMarket Cap-174066P/E (TTM)

Serina Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-122.43%-1.58M

-863.6K

-709K

7.78%-2.08M

-2.25M

Net income from continuing operations

-669.18%-9.44M

--808.59K

--1.66M

-112.07%-2.68M

---1.26M

Operating gains losses

----

---291.4K

---172K

159.80%134.79K

---225.38K

Depreciation and amortization

92.31%25K

--29.58K

--13K

83.63%61.27K

--33.37K

Other non cash items

45.65%67K

--32.12K

--46K

221.31%148.26K

---122.21K

Change In working capital

151.08%698K

--105.55K

--278K

98.42%-11.94K

---754.79K

-Change in receivables

----

-99.91%1.11K

--1.27M

-Change in prepaid assets

-5,800.00%-57K

--149

--1K

430.63%1.51K

--284

-Change in payables and accrued expense

151.40%807K

--183.61K

--321K

98.98%-3.89K

---382.19K

-Change in other current liabilities

-18.18%-52K

---41.2K

---44K

-309.64%-164.16K

---40.08K

-Change in other working capital

----

109.55%153.5K

---1.61M

Cash from discontinued investing activities

Operating cash flow

-122.43%-1.58M

---863.6K

---709K

7.78%-2.08M

---2.25M

Investing cash flow

Cash flow from continuing investing activities

-14K

-315.34K

19.14%980.94K

823.32K

Net PPE purchase and sale

---14K

---315.34K

--0

91.07%-9.68K

---108.43K

Net investment purchase and sale

----

6.32%990.62K

--931.76K

Cash from discontinued investing activities

Investing cash flow

---14K

---315.34K

--0

19.14%980.94K

--823.32K

Financing cash flow

Cash flow from continuing financing activities

-72.96%2.73M

-11.21K

10.09M

21.80%1.31M

1.08M

Net issuance payments of debt

-76.34%2.39M

---12.14K

--10.09M

10,231.31%1.31M

---12.91K

Net common stock issuance

----

--4.42K

--0

Net preferred stock issuance

----

--0

--90.15K

Proceeds from stock option exercised by employees

--4K

--936

--0

----

Net other financing activities

--337K

----

--1M

Cash from discontinued financing activities

Financing cash flow

-72.96%2.73M

---11.21K

--10.09M

21.80%1.31M

--1.08M

Net cash flow

Beginning cash position

1,332.14%7.62M

--9.91M

--532K

-52.66%314.85K

--665.06K

Current changes in cash

-87.88%1.14M

---1.19M

--9.38M

162.07%217.38K

---350.21K

End cash Position

-11.66%8.76M

--8.72M

--9.91M

69.04%532.23K

--314.85K

Free cash flow

-124.40%-1.59M

---1.18M

---709K

11.61%-2.09M

---2.36M

Currency Unit

USD

	(Q1)Mar 31, 2024	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-122.43%-1.58M	-863.6K	-709K	7.78%-2.08M	-2.25M
Net income from continuing operations	-669.18%-9.44M	--808.59K	--1.66M	-112.07%-2.68M	---1.26M
Operating gains losses	----	---291.4K	---172K	159.80%134.79K	---225.38K
Depreciation and amortization	92.31%25K	--29.58K	--13K	83.63%61.27K	--33.37K
Other non cash items	45.65%67K	--32.12K	--46K	221.31%148.26K	---122.21K
Change In working capital	151.08%698K	--105.55K	--278K	98.42%-11.94K	---754.79K
-Change in receivables	----	----	----	-99.91%1.11K	--1.27M
-Change in prepaid assets	-5,800.00%-57K	--149	--1K	430.63%1.51K	--284
-Change in payables and accrued expense	151.40%807K	--183.61K	--321K	98.98%-3.89K	---382.19K
-Change in other current liabilities	-18.18%-52K	---41.2K	---44K	-309.64%-164.16K	---40.08K
-Change in other working capital	----	----	----	109.55%153.5K	---1.61M
Cash from discontinued investing activities
Operating cash flow	-122.43%-1.58M	---863.6K	---709K	7.78%-2.08M	---2.25M
Investing cash flow
Cash flow from continuing investing activities	-14K	-315.34K	0	19.14%980.94K	823.32K
Net PPE purchase and sale	---14K	---315.34K	--0	91.07%-9.68K	---108.43K
Net investment purchase and sale	----	----	----	6.32%990.62K	--931.76K
Cash from discontinued investing activities
Investing cash flow	---14K	---315.34K	--0	19.14%980.94K	--823.32K
Financing cash flow
Cash flow from continuing financing activities	-72.96%2.73M	-11.21K	10.09M	21.80%1.31M	1.08M
Net issuance payments of debt	-76.34%2.39M	---12.14K	--10.09M	10,231.31%1.31M	---12.91K
Net common stock issuance	----	----	----	--4.42K	--0
Net preferred stock issuance	----	----	----	--0	--90.15K
Proceeds from stock option exercised by employees	--4K	--936	--0	----	----
Net other financing activities	--337K	----	----	----	--1M
Cash from discontinued financing activities
Financing cash flow	-72.96%2.73M	---11.21K	--10.09M	21.80%1.31M	--1.08M
Net cash flow
Beginning cash position	1,332.14%7.62M	--9.91M	--532K	-52.66%314.85K	--665.06K
Current changes in cash	-87.88%1.14M	---1.19M	--9.38M	162.07%217.38K	---350.21K
End cash Position	-11.66%8.76M	--8.72M	--9.91M	69.04%532.23K	--314.85K
Free cash flow	-124.40%-1.59M	---1.18M	---709K	11.61%-2.09M	---2.36M
Currency Unit	USD	USD	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall